Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 09:01:44 GMT 2025
by
admin
on
Wed Apr 02 09:01:44 GMT 2025
|
| Protein Type | PEPTIDE |
| Protein Sub Type | ANTIBACTERIAL PEPTIDE |
| Sequence Type | COMPLETE |
| Record UNII |
C8ECW4KP2L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
723219
Created by
admin on Wed Apr 02 09:01:44 GMT 2025 , Edited by admin on Wed Apr 02 09:01:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C8ECW4KP2L
Created by
admin on Wed Apr 02 09:01:44 GMT 2025 , Edited by admin on Wed Apr 02 09:01:44 GMT 2025
|
PRIMARY | |||
|
847061-43-2
Created by
admin on Wed Apr 02 09:01:44 GMT 2025 , Edited by admin on Wed Apr 02 09:01:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
Synthetic cationic peptide antibiotic with a broad
antimicrobial spectrum. Exact mechanism of
how this class of agents works on bacteria has not been yet elucidated though it is considered to target bacterial cell wall
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|